Potential role for statins in the treatment of chronic HCV infection

被引：4
|
作者：
Zhu, Qianqian [1 ]
Han, Qunying [1 ]
Liu, Zhengwen [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Infect Dis, Xian 710061, Shaanxi Provinc, Peoples R China
来源：
FUTURE VIROLOGY | 2013年 / 8卷 / 08期
关键词：
chronic hepatitis C; direct-acting antiviral; host-targeting agent; IFN-; ribavirin; statin; treatment; CHRONIC HEPATITIS-C; VIRUS-RNA REPLICATION; PEGYLATED INTERFERON; COMBINATION THERAPY; ANTIVIRAL EFFICACY; PLUS RIBAVIRIN; GENOTYPE; 1B; OPEN-LABEL; FLUVASTATIN; RESISTANCE;
D O I：
10.2217/fvl.13.70
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：727 / 729
页数：3
相关论文
共 50 条
  • [41] MARGINAL ZONE LYMPHOMA AND HCV INFECTION: ROLE OF ANTIVIRAL TREATMENT
    Pellicelli, Adriano M.
    Barbaro, Giuseppe
    Zoli, Valerio
    Remotti, Daniele
    Villani, Roberto
    Nosotti, Lorenzo
    Picardi, Antonio
    Gentilucci, Umberto Vespasiani
    Soccorsi, Fabrizio
    HEPATOLOGY, 2008, 48 (04) : 1178A - 1179A
  • [42] Successful Treatment of Chronic HCV Infection Should Not Preclude Kidney Donation to an HCV Negative Recipient
    Cruzado, J. M.
    Gil-Vernet, S.
    Castellote, J.
    Bestard, O.
    Melilli, E.
    Grinyo, J. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (10) : 2773 - 2774
  • [43] Liver histology: Chronic HCV vs chronic HCV/HGV infection
    Davis, GL
    Lau, JYN
    HEPATOLOGY, 1996, 24 (04) : 1049 - 1049
  • [44] THE POTENTIAL OF STATINS IN THE TREATMENT OF OSTEOPOROSIS
    Petkovic-Mirkovic, Z.
    Mirkovic, J.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S207 - S207
  • [45] Cryoblobulinemia—a useful predictor of treatment response in patients with chronic HCV infection?
    Katrina Ray
    Nature Reviews Gastroenterology & Hepatology, 2011, 8 (1) : 6 - 6
  • [46] Treatment of HCV chronic infection with amantadine and interferon in elderly patient.
    De Angelis, A
    Russo, F
    D'Alessandri, L
    Bernardeschi, D
    Marinelli, RMA
    Ricci, GL
    HEPATOLOGY, 1998, 28 (04) : 208A - 208A
  • [47] Response to the comment made on Treatment of HCV infection in chronic kidney disease
    Garcia Agudo, R.
    Aoufi Rabih, S.
    NEFROLOGIA, 2011, 31 (05): : 607 - 608
  • [48] Interferon treatment of chronic HCV infection: An economic analysis of different strategies
    Younossi, Z
    McHutchison, JG
    GASTROENTEROLOGY, 1996, 110 (04) : A47 - A47
  • [49] Modelling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infection
    Canini, Laetitia
    Guedj, Jeremie
    Chatterjee, Anushree
    Lemenuel-Diot, Annabelle
    Smith, Patrick F.
    Perelson, Alan S.
    ANTIVIRAL THERAPY, 2016, 21 (04) : 297 - 306
  • [50] POTENTIAL USE OF STATINS IN PREVENTION AND TREATMENT OF DENGUE VIRUS INFECTION: IN VITRO STUDY
    Martinez-Gutierrez, Marlen
    Gallego-Gomez, Juan C.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 147 - 147
12345